The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
The latest from CDMOs, CMOs, and suppliers in COVID-19 projects featuring AGC Biologics, Almac, and Advent Srl.
Biologics Manufacturing
Advent To Manufacture COVID-19 Vaccine for Oxford University Advent Srl, a CDMO providing viral vector...
Emergent BioSolutions, a Gaithersburg, Maryland-based specialty biopharmaceutical company and contract manufacturer, has been issued a $628-million task order under an existing contract with the Biomedical Advanced Research and Development...
The latest from CDMOs, CMOs, and suppliers in COVID-19 projects featuring MilliporeSigma, CordenPharma, Oxford Biomedica, and Kindred Biosciences.
Biologics Manufacturing
AstraZeneca, Oxford Biomedica in Mfg Pact for COVID-19 VaccineAstraZeneca...
GlaxoSmithKline and Samsung Biologics, a contract biologics manufacturer, have entered into a $231-million, eight-year partnership under which Samsung Biologics will provide GSK with additional capacity to manufacture and supply GSK’s...
Thermo Fisher Scientific has launched its $11.5-billion takeover offer for Qiagen, a provider of molecular diagnostics and sample preparation technologies. Thermo Fisher had previously announced the proposed acquisition earlier this year (March...
The latest from CDMOs, CMOs, and suppliers in COVID-19 projects featuring AGC Biologics, Thermo Fisher Scientific, and Univercells.
Biologics Manufacturing
AGC Biologics, Takara Bio Enter Pact for COVID-19 Vaccine Candidate AGC Biologics, a CDMO...
The Biomedical Advanced Research and Development Authority (BARDA), part of the office of Assistant Secretary for Preparedness and Response (ASPR) at the US Department of Health and Human Services (HHS), has entered into a $354-million agreement...
The latest news from CDMOs, CMOs, and suppliers featuring WuXi Advanced Therapies, WuXi Biologics, Catalent, Sharp, Colorcon, and Rentschler Biopharma.
Biologics Manufacturing
WuXi Biologics To Build New Biomanufacturing Facility in US WuXi...
Thermo Fisher Scientific is expanding capacity for viral vector development and manufacturing services with the construction of a new commercial manufacturing site in Plainville, Massachusetts. The $180-million project will more...
The latest news from CDMOs, CMOs, and suppliers featuring MilliporeSigma, Evonik, Marken, Ori Biotech and CellGenix.
Biologics Manufacturing
MilliporeSigma Launches Next Tool of Bioprocessing Software Suite Millipore Sigma has launched the next...
The latest from CDMOs, CMOs, and suppliers in COVID-19 projects featuring Catalent, Sterling Pharma, ABL, and Singota.
Chemicals/Chemical API Manufacturing
Sterling Begins Hydroxychloroquine Production in the...
The latest from CDMOs and suppliers in COVID-19 efforts featuring Seqens, Catalent, MilliporeSigma, Recipharm, Fujifilm Diosynth, AMRI, and Ajinomoto Bio-Pharma.
Chemicals/Chemical API Manufacturing
Seqens Supports Potential COVID-19...
The latest news from CDMOs, CMOs, and suppliers featuring Seqens, Adare Pharmaceuticals, AGC Biologics, Avid Bioservices, Avantor, Kindeva, and Univercells.
Chemicals/Chemical API Manufacturing
Seqens To Expand Flow-Chemistry CapabilitiesSeqens...
Sartorius has closed its $825-million acquisition of select life-science businesses of Danaher Corporation, a Washington, D.C.-headquartered science and technology company. Danaher divested the businesses to satisfy regulatory requirements as part...
Lonza and Moderna, a clinical-stage biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, have formed a 10-year pact to enable manufacturing of up to one billion doses per year of Moderna’s mRNA vaccine (mRNA-1273)...
